ArticleDiabetology & metabolic syndrome2016

Effects of nateglinide and rosiglitazone on pancreatic alpha- and beta-cells, GLP-1 secretion and inflammatory markers in patients with type 2 diabetes: randomized crossover clinical study.

Glauce Cordeiro Ulhôa Tostes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.